Induction of decay-accelerating factor by cytokines or the membrane- attack complex protects vascular endothelial cells against complement deposition

Blood

Volumn 94, Issue 5, 1999, Pages 1673-1682

  Mason, Justin C ^a   Yarwood, Helen ^b   Sugars, Katharine ^b   Morgan, B Paul ^b   Davies, Kevin A ^b   Haskard, Dorian O ^b  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD59 ANTIGEN; COMPLEMENT COMPONENT C3; COMPLEMENT MEMBRANE ATTACK COMPLEX; CYTOKINE; DECAY ACCELERATING FACTOR; GAMMA INTERFERON; MEMBRANE COFACTOR PROTEIN; MESSENGER RNA; MONOCLONAL ANTIBODY; PROTEIN KINASE C INHIBITOR; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL PROTECTION; COMPLEMENT ACTIVATION; COMPLEMENT DEPOSITION; CONTROLLED STUDY; ENDOTHELIUM CELL; FEEDBACK SYSTEM; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; INFLAMMATION; MICROVASCULATURE; PRIORITY JOURNAL; PROTEIN INDUCTION; VASCULAR ENDOTHELIUM;

EID: 0033198618     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v94.5.1673.417a05_1673_1682     Document Type: Article

References (57)

1. Morgan BP: Complement membrane attack on nucleated cells: Resistance, recovery and non-lethal effects. Biochem J 264:1, 1989
2. Liszewski MK, Farries TC, Lublin DM, Rooney IA, Atkinson JP: Control of the complement system. Adv Immunol 61:201, 1996
3. Lublin DM, Atkinson JP: Decay-accelerating factor: Biochemistry, molecular biology and function. Annu Rev Immunol 7:35, 1989
4. Liszewski MK, Post TW, Atkinson JP: Membrane cofactor protein (MCP or CD46): Newest member of the regulators of the complement activation gene cluster. Annu Rev Immunol 9:431, 1991
5. Davies A, Simmons DL, Hale G, Harrison RA, Tighe H, Lachmann PJ, Waldmann H: CD59, an LY-6-like protein expressed in human lymphoid cells, regulates the action of the complement membrane attack complex on homologous cells. J Exp Med 170:637, 1989
6. Robson SC, Candinas D, Hancock WW, Wrighton C, Winkler H, Bach F: Role of endothelial cells in transplantation. Im Arch Allergy Immunol 106:305, 1995
7. Biesecker G, Katz S, Koffler D: Renal localization of the membrane attack complex in systemic lupus erythematosus nephritis. J Exp Med 154:1779, 1981
8. Asghar SS: Membrane regulators of complement activation and their aberrant expression in disease. Lab Invest 72:254, 1995
9. Torzewski M, Torzewski J, Bowyer DE, Waltenberger J, Fitzsimmons C, Hombach V, Gabbert HE: Immunohistochemical colocalization of the terminal complex of human complement and smooth muscle cell alpha-actin in early atherosclerotic lesions. Arterioscler Thromb Vasc Biol 17:2448, 1997
10. Asch AS, Kinoshita T, Jaffe EA, Nussenzweig V: Decay-accelerating factor is present on cultured human umbilical vein endothelial cells. J Exp Med 163:221, 1986
11. McNeamey T, Ballard L, Seya T, Atkinson JP: Membrane cofactor protein of complement is present on human fibroblast, epithelial, and endothelial cells. J Clin Invest 84:538, 1989
12. Brooimans RA, van Wieringen PAM, van Es LA, Daha MR: Relative roles of decay-accelerating factor, membrane cofactor protein, and CD59 in the protection of human endothelial cells against complement mediated lysis. Eur J Immunol 22:3135, 1992
13. Pober JS, Cotran RS: Cytokines and endothelial cell biology. Physiol Rev 70:427, 1990
14. Cines DB, Pollak ES, Buck CA, Loscalzo J, Zimmerman GA, McEver RP, Pober JS, Wick TM, Konkle BA, Schwarte BS, Barnathan ES, McCrae KR, Hug BA, Schmidt AM, Stern DM: Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood 91:3527, 1998
15. Ward PA: Role of complement in lung inflammatory injury. Am J Pathol 149:1081, 1996
16. Lozada C, Levin RI, Huie M, Hirschhorn R, Naime D, Whitlow M, Recht PA, Golden B, Cronstein BN: Identification of C1q as the heat-labile serum cofactor required for immune complexes to stimulate endothelial expression of the adhesion molecules E-selectin and intercellular and vascular cell adhesion molecules 1. Proc Natl Acad Sci USA 92:8378, 1995
17. Foreman KE, Vaporciyan AA, Bonish BK, Jones ML, Johnson KJ, Glovsky MM, Eddy SM, Ward PA: C5a-induced expression of P-selectin in endothelial cells. J Clin Invest 94:1147, 1994
18. Saadi S, Holzknecht RA, Patte CP, Stern DM, Platt JL: Complement-mediated regulation of tissue factor activity in endothelium. J Exp Med 182:1807, 1995
19. Tedesco F, Pausa M, Nardon E, Introna M, Mantovani A, Dobrina A: The cytolytically inactive terminal complement complex activates endothelial cells to express adhesion molecules and tissue factor procoagulant activity. J Exp Med 185:1619, 1997
20. Hattori R, Hamilton KK, McEver RP, Sims PJ: Complement proteins C5b-9 induce secretion of high molecular weight multimers of endothelial von Willebrand factor and translocation of granule membrane protein GMP-140 to the cell surface. J Biol Chem 264:9053, 1989
21. Kilgore KS, Flory CM, Miller BF, Evans VM, Warren JS: The membrane attack complex of complement induces interleukin-8 and monocyte chemoattractant protein-1 secretion from human umbilical vein endothelial cells. Am J Pathol 149:953, 1996
22. Kilgore KS, Shen JP, Miller BF, Ward PA, Warren JS: Enhancement by the complement membrane attack complex of tumor necrosis factor-alpha-induced endothelial cell expression of E-selectin and ICAM-1. J Immunol 155:1434, 1995
23. Suttorp N, Seeger W, Zinsky S, Bhakdi S: Complement complex C5b-8 induces PGI2 formation in cultured endothelial cells. Am J Physiol 253:C13, 1987
24. Benzaquen LR, Nicholson Weller A, Halperin JA: Terminal complement proteins C5b-9 release basic fibroblast growth factor and platelet-derived growth factor from endothelial cells. J Exp Med 179:985, 1994
25. Bryant RW, Granzow CA, Siegel MI, Egan RW, Billah MM: Phorbol esters increase synthesis of decay-accelerating factor, a phosphatidylinositol-anchored surface protein, in human endothelial cells. J Immunol 144:593, 1990
26. Bryant RW, Granzow CA, Siegel MI, Egan RW, Billah MM: Wheat germ agglutinin and other selected lectins increase synthesis of decay-accelerating factor in human endothelial cells. J Immunol 147:1856, 1991
27. Tsuji S, Kazuhiko K, Nagasawa S: Decay-accelerating factor on human umbilical vein endothelial cells. Its histamine-induced expression and spontaneous rapid shedding from the cell surface. J Immunol 152:1404, 1994
28. Moutabarrik A, Nakanishi I, Namiki M, Hara T, Matsumoto M, Ishibashi M, Okuyama A, Zaid D, Seya T: Cytokine-mediated regulation of the surface expression of complement regulatory proteins, CD46(MCP), CD55(DAF), and CD59, on human vascular endothelial cells. Lymphokine Cytokine Res 12:167, 1993
29. Davis PD, Hill CH, Keech E, Lawton G, Nixon JS, Sedgwick AD, Wadsworth J, Westmacott D, Wilkinson SE: Potent selective inhibitors of protein kinase C. FEBS Lett 259:61, 1989
30. Wellicome SM, Thornhill MH, Pitzalis C, Thomas DS, Lanchbury JS, Panayi GS, Haskard DO: A monoclonal antibody that detects a novel antigen on endothelial cells that is induced by tumor necrosis factor, IL-1, or lipopolysaccharide. J Immunol 144:2558, 1990
31. Mason JC, Yarwood H, Tárnok A, Sugars K, Harrison AA, Robinson PJ, Haskard DO: Human Thy-1 is cytokine inducible on vascular endothelial cells and is a signaling molecule regulated by protein kinase C. J Immunol 157:874, 1996
32. Ades EW, Candal FJ, Swerlick RA, George VG, Summers S, Bosse DC, Lawley TJ: HMEC-1 - Establishment of an immortalized human microvascular endothelial cell line. J Invest Dermatol 99:683, 1992
33. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156, 1987
34. Medof ME, Lublin DM, Holers VM, Ayers DJ, Getty RR, Leykam JF, Atkinson JP, Tykocinski ML: Cloning and characterization of cDNAs encoding the complete sequence of decay-accelerating factor of human complement. Proc Natl Acad Sci USA 84:2007, 1987
35. Sambrook J, Fritsch EF, Maniatis T: Extraction, purification, and analysis of messenger RNA from eukaryotic cells, in Ford N, Nolan C, Ferguson M (eds): Molecular Cloning: A Laboratory Manual (ed 2). Cold Spring Harbor, NY, Cold Spring Harbor Laboratory, 1989, p 7
36. Mason JC, Yarwood H, Sugars K, Haskard DO: Human umbilical vein and dermal microvascular endothelial cells show heterogeneity in response to activation of protein kinase C. Am J Physiol 273:C1233, 1997
37. Caras IW, Davitz MA, Rhee L, Weddell G, Martin DW Jr, Nussenzweig V: Cloning of decay-accelerating factor suggests novel use of splicing to generate two proteins. Nature 325:545, 1987
38. O'Connell PJ, McKenzie A, Fisicaro N, Rockman SP, Pearse MJ, d'Apice AJ: Endoglin: A 180-kD endothelial cell and macrophage restricted differentiation molecule. Clin Exp Immunol 90:154, 1992
39. Kuijpers TW, Hoogerwerf M, Mul FPJ, Roos D: Binding of workshop endothelial section mAb to resting and activated human umbilical cord vein endothelial cells, platelets, and neutrophilic granulocytes, in Schlossman SF, Boumsell L, Gilks W, Harlan JM, Kishimoto T, Morimito C, Ritz J, Shaw S, Silverstein R, Springer T, Tedder TF, Todd RF (eds): Leucocyte Typing (ed 5). White Cell Differentiation Antigens, vol 2. Oxford, UK: Oxford University Press, 1995, p 1807
40. Rooney IA, Davies A, Morgan BP: Membrane attack complex (MAC)-mediated damage to spermatozoa: Protection of the cells by the presence on their membranes of MAC inhibitory proteins. Immunology 75:499, 1992
41. Yamamoto H, Blaas P, Nicholson Weller A, Hansch GM: Homologous species restriction of the complement-mediated killing of nucleated cells. Immunology 70:422, 1990
42. Thomas DJ, Lublin DM: Identification of 5′-flanking regions affecting the expression of the human decay accelerating factor gene and their role in tissue-specific expression. J Immunol 150:151, 1993
43. Uesu T, Mizuno M, Inoue H, Tomoda J, Tsuji T: Enhanced expression of decay accelerating factor and CD59/homologous restriction factor 20 on the colonic epithelium of ulcerative colitis. Lab Invest 72:587, 1995
44. Carney DF, Lang TJ, Shin ML: Multiple signal messengers generated by terminal complement complexes and their role in terminal complement complex elimination. J Immunol 145:623, 1990
45. Cosio FG, Sedmak DD, Mahan JD, Nahman NS Jr: Localization of decay accelerating factor in normal and diseased kidneys. Kidney Int 36:100, 1989
46. Tarkowski A, Trollmo C, Seifert PS, Hansson GK: Expression of decay-accelerating factor on synovial lining cells in inflammatory and degenerative arthritides. Rheumatol Int 12:201, 1992
47. Bach FH, Hancock WW, Ferran C: Protective genes expressed in endothelial cells: A regulatory response to injury. Immunol Today 18:483, 1997
48. +-initiated activation of cellular protein kinases. J Biol Chem 262:13674, 1987
49. Kilgore KS, Schmid E, Shanley TP, Flory CM, Maheswari V, Tramontini NL, Cohen H, Ward PA, Friedl HP, Warren JS: Sublytic concentrations of the membrane attack complex of complement induce endothelial interleukin-8 and monocyte chemoattractant protein-1 through nuclear factor-kappa B activation. Am J Pathol 150:2019, 1997
50. Hindmarsh EJ, Marks RM: Decay-accelerating factor is a component of subendothelial extracellular matrix in vitro, and is augmented by activation of protein kinase C. Eur J Immunol 28:1052, 1998
51. Mason JC, Yarwood H, Harrison AA, Davies KAA, Haskard DO: Expression and regulation of complement regulatory proteins CD59 and decay-accelerating factor (DAF) on endothelial cells. Arthritis Rheum 40:S77, 1997 (suppl)
52. Ripoche J, Mitchell JA, Erdei A, Madin C, Moffatt B, Mokoena T, Gordon S, Sim RB: Interferon gamma induces synthesis of complement alternative pathway proteins by human endothelial cells in culture. J Exp Med 168:1917, 1988
53. Brooimans RA, Hiemstra PS, van der Ark AAJ, Sim RB, van Es LA, Daha MR: Biosynthesis of complement factor H by human umbilical vein endothelial cells. Regulation by T cell growth factor and IFN-gamma. J Immunol 142:2024, 1989
54. Hindmarsh EJ, Marks RM: Complement activation occurs on subendothelial extracellular matrix. J Immunol 160:6128, 1998
55. Bhakdi S, Fassbender W, Hugo F, Carreno MP, Berstecher C, Malasit P, Kazatchkine MD: Relative inefficiency of terminal complement activation. J Immunol 141:3117, 1988
56. Hamann J, Vogel B, van Schijndel GMW, van Lier RAW: The seven-span transmembrane receptor CD97 has a cellular ligand (CD55 DAF). J Exp Med 184:1185, 1996
57. Xia P, Aiello LP, Ishii H, Jiang ZY, Park DJ, Robinson GS, Takagi H, Newsome WP, Jirousek MR, King GL: Characterization of vascular endothelial cell growth factor's effect on the activation of protein kinase C, its isoforms, and endothelial cell growth. J Clin Invest 98:2018, 1996